Patents Assigned to Genotox Laboratories
  • Patent number: 11946861
    Abstract: This disclosure relates to methods of characterizing a urine sample from a subject.
    Type: Grant
    Filed: August 2, 2021
    Date of Patent: April 2, 2024
    Assignee: Genotox Laboratories
    Inventors: Nicholas D. Laude, William S. Edgemond, Keqin Gregg
  • Publication number: 20220276156
    Abstract: This disclosure relates to methods of characterizing a urine sample from a subject.
    Type: Application
    Filed: August 2, 2021
    Publication date: September 1, 2022
    Applicant: Genotox Laboratories
    Inventors: Nicholas D. Laude, William S. Edgemond, Keqin Gregg
  • Patent number: 11079320
    Abstract: This disclosure relates to methods of characterizing a urine sample from a subject.
    Type: Grant
    Filed: September 9, 2019
    Date of Patent: August 3, 2021
    Assignee: Genotox Laboratories
    Inventors: Nicholas D. Laude, William S. Edgemond, Keqin Gregg
  • Publication number: 20200116628
    Abstract: This disclosure relates to methods of characterizing a urine sample from a subject.
    Type: Application
    Filed: September 9, 2019
    Publication date: April 16, 2020
    Applicant: Genotox Laboratories
    Inventors: Nicholas D. Laude, William S. Edgemond, Keqin Gregg
  • Patent number: 10451544
    Abstract: This disclosure relates to methods of characterizing a urine sample from a subject.
    Type: Grant
    Filed: October 11, 2017
    Date of Patent: October 22, 2019
    Assignee: Genotox Laboratories
    Inventors: Nicholas D. Laude, William S. Edgemond, Keqin Gregg
  • Publication number: 20190170639
    Abstract: This disclosure relates to methods of characterizing a urine sample from a subject.
    Type: Application
    Filed: October 11, 2017
    Publication date: June 6, 2019
    Applicant: Genotox Laboratories
    Inventors: Nicholas D. Laude, William S. Edgemond, Keqin Gregg